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Background. Obesity studies are often performed on population data. We sought to examine the incidence of obesity and its
associated comorbidities in a single freestanding children’s hospital. Methods. We performed a retrospective analysis of all visits
to Boston Children’s Hospital from 2000 to 2012. This was conducted to determine the incidence of obesity, morbid obesity, and
associated comorbidities. Each comorbidity was modeled independently. Incidence rate ratios were calculated, as well as odds
ratios. Results. A retrospective review of 3,185,658 person-years in nonobese, 26,404 person-years in obese, and 25,819 person-
years in the morbidly obese was conducted. Annual rates of all major comorbidities were increased in all patients, as well as in
our obese and morbidly obese counterparts. Incidence rate ratios (IRR) and odds ratios (OR) were also significantly increased
across all conditions for both our obese and morbidly obese patients. Conclusions. These data illustrate the substantial increases in
obesity and associated comorbid conditions. Study limitations include (1) single institution data, (2) retrospective design, and (3)
administrative undercoding. Future treatment options need to address these threats to longevity and quality of life.
1. Introduction
The increased prevalence of overweight and obese children
i sn o tn e w ,y e ti th a sb e e nv i e w e dm o r er e c e n t l ya sap u b l i c
health epidemic [1–3]. According to the Centers for Disease
Control and Prevention (CDC), approximately 12.5 million,
or 17%, of American children are obese. More recent studies
show that over 10% of 2–5-year-olds would be classified as
overweight, whereas this number increases to 15% in the
adolescent age group [4].
Interestingly, in 2000 the US Preventive Services Task
Force(USPSTF)didnotfindenoughevidencetorecommend
fororagainstroutinescreeningforoverweightstatusineither
children or adolescents as a means of mitigating further
health sequelae, yet now the task force is revisiting this
idea as of 2010 [5]. It is known that a higher prevalence of
comorbid diseases attributable to obesity is seen in both
adultsandchildren, especially modifiable cardiovascularrisk
factors and sequelae. In the long-standing Bogalusa Heart
study,bodymassindexes(BMI)performedinchildhoodand
adolescence, as a measurement for obesity, predicted intima-
media thickness in adults [6].
O b e s i t yi sn o to n l yr e l a t e dt om o d i fi a b l ec a r d i o v a s c u l a r
riskfactors,butalsotoseveralotherhealth-relatedconditions
that may persist or worsen in adulthood [7, 8]. This includes
asthma, orthopedic disorders, depression and anxiety, liver
abnormalities, and endocrine related issues including type 2
diabetes, hyperlipidemia, and polycystic ovarian syndrome
(PCOS) [9]. Further studies may reflect resolution in these
conditions with increased awareness of the association
betweenobesityandmultiplecomorbidconditions.However,
these studies are often performed on population-based level.
Therefore, we sought to examine the incidence of the diverse
sequelae of obesity and morbid obesity, as evidenced by
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Table 1: Study design: inclusion criteria and definitions of patient groups in a specific year.
Patient group Inclusion/exclusion filters and definitions
All patients patients with encounter start dates within a specific year
a
All patients with condition Include (condition criteria + date criteria)
Obese patients Include (obesity criteria + date criteria)
Obese patients with condition Include (obesity criteria + date criteria)
Include (condition criteria + date criteria)
Obese patients without condition Include (obesity criteria + date criteria)
Exclude (condition criteria + date criteria)
Nonobese patients (All patients) minus (obese patients)
Nonobese patients with condition (All patients with condition) minus
(obese patients with condition)
Nonobese patients without condition (Nonobese patients) minus
(nonobese patients with condition)
aData provided by the Clinical Research Informatics group at Boston Children’s Hospital.
its associated comorbidities in a single, large, free-standing,
children’s hospital.
2. Methods
2.1.DataSource. Thisstudywasconductedwiththeapproval
of the Institutional Review Board at Boston Children’s Hos-
pital(IRB-P00001304).Noindividualpatienthealthinforma-
tion was collected in this study. All inpatient and outpatient
visits to Boston Children’s Hospital between January 1, 2000,
and December 31, 2012, were included in the dataset. These
visit were queried through the Informatics for Integrating
BiologyandtheBedside(i2b2)datawarehouseplatform(i2b2
v. 1.4; USA)implemented at theinstitution[10]. Thei2b2 sys-
temallowedinvestigatorstoperformqueriesonanenterprise
data repository through its web-based interface [11]. Selected
demographics information in Epic computer system and
information on hospital-billed diagnoses in Cerner, in the
formofInternationalClassificationofDiseases,9thRevision,
Clinical Modification (ICD-9) codes, were available through
i2b2.
Theda tacollectedwasnotstra tifiedbasedonage,gender ,
nor whether the visit was an inpatient or outpatient visit
in nature. Using the i2b2 web client, queries were entered
in the form of inclusion or exclusion “filter” groups based
on ICD-9 codes and date criteria, with date criteria based
on the start date of the encounters. Our queries and cal-
culations are described in Table 1.W eo b t a i n e dc o u n t sf o r
different “patient groups” by year based on the respective
administrative diagnosis. Temporal constraints were set to
treat all groups independently as opposed to have the “filter”
groups occur in the same financial encounter. To account for
the children and adolescents in our study population, both
adult and pediatric ICD-9 criteria were used in determining
obesitystatus,utilizingboththeBMIcategorizationstandard
as defined by World Health Organization and the percentile
standardasdefinedbyAmericanMedicalAssociation[12,13].
ICD-9 code criteria for obesity status and comorbid con-
ditions are further described in Table 2. A single condition
was considered met if one or more of its ICD-9 criteria
Table 2: Study design with ICD-9-CM filter criteria.
Condition ICD-9-CM codes
Obesity condition
Obese V85.4, V85.54, 278.01,
V85.3, V85.53, 278.00
Morbidly obese V85.4, V85.54, 278.01
Major comorbid condition
Type 2 diabetes 250.00, 250.01, 250.02,
250.03
Hyperlipidemia 272.0, 271.1, 272.2, 272.3,
272.4
Hypertension 401, 405
Sleep apnea 327.23
Asthma 493
Depression 296.2, 296.3, 300.4, 311
Orthopedic 732.2, 732.4, 736.4,
736.42
Other comorbid conditions
Acanthosis nigricans 701.2
NASH 571.8
PCOS 256.4
Glucose intolerance 790.2
Insulin resistance 277.7
LVH 429.3
Elevated blood pressure 796.2
Pseudotumor cerebri 348.2
ICD-9-CM: International Classification of Diseases, 9th Revision, Clinical
Modification; NASH: nonalcoholic steatohepatitis; PCOS: polycystic ovary
syndrome; LVH: left ventricular hypertrophy.
were coded. To help limit the number of “double-counting,”
a patient was only counted once in each “patient group”
regardless of how many ICD-9 criteria of the same condition
the patient has met in that particular year.ISRN Obesity 3
Figure1:Thisfigureillustratestheoverallpercentage(%)ofpatients
coded as obese and morbidly obese from 2000–2012.
2.2. Statistical and Data Analysis. The main comorbid con-
ditions included diabetes mellitus, hypertension, hyperlipi-
demia, sleep apnea, degenerative joint disease, asthma, and
depression. Overall rates of these related comorbid condi-
tions were calculated for obese and morbidly obese versus
nonobese patients, as well as the annual increase for all
patients over that same time period. Other obesity-related
comorbid conditions that we examined included acanthosis
nigricans, nonalcoholic steatohepatitis (NASH), PCOS, glu-
cose intolerance, insulin resistance, left ventricular hypertro-
phy (LVH), elevated blood pressure, and pseudotumor cere-
bri. The incidence rate ratio (IRR) was then calculated to see
if obese and morbidly obese patients were disproportionately
affected by these conditions. An odds ratio (OR) was also
calculated.
3. Results
In total, a retrospective review of 3,185,658 person-years in
nonobese, 26,404 person-years in obese, and 25,819 person-
years in the morbidly obese children was conducted. The
annual rate of patients coded with obesity increased from
0.86% in 2000 to approximately 2.78% in 2012 at our insti-
tution as shown in Figure 1. Figure 1 also illustrates that the
annual rate of patients coded with morbid obesity increased
f r o m0 . 3 4 %i n2 0 0 0t o1 . 5 1 %i n2 0 1 2 .W h e nc o m p a r i n g
differing major comorbid conditions, it appeared that the
proportions of patients coded as obese or morbidly obese
remained constant at the various time points including
2000, 2005, and 2010. On the other hand, when compar-
ing the differing preconditions, it appeared that there was
a slight increase in the proportions of patients coded as
morbidly obese versus obese. This was especially prominent
in the cohort of endocrine conditions including acanthosis
nigricans, PCOS, and insulin resistance. A summary of the
findings was displayed in Figures 2 and 3.
The annual rate of all major comorbidities (diabetes mel-
litus,hypertension,hyperlipidemia,sleepapnea,degenerative
joint disease, asthma, and depression) increased in all pedi-
atric patients over the study period. Other obesity-related
comorbid conditions, or preconditions, including acanthosis
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Figure 2: This figure illustrates the percentage (%) of patients with
majorcomorbidconditionscodedasobeseandmorbidlyobese(not
obese) at time points 2000, 2005, and 2010.
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Figure 3: This figure illustrates the percentage (%) of patients with
“preconditions” coded as obese and morbidly obese (not obese) at
time points 2000, 2005, and 2010.
nigricans, NASH, PCOS, glucose intolerance, insulin resis-
tance, LVH, elevated blood pressures, hypertension, and
pseudotumorcerebri,werealsoincreasedamongallpediatric
patients over the study period. However, when comparing
annualratesinobesepatientsalone,theannualratesforobese
patients were higher across all categories as compared to the
annual rates calculated in all patients (Table 3).
All of the obesity-related comorbidities were higher
among obese versus non-obese patients over the time period
from 2000 to 2012. All comorbidities were also higher in the
morbidlyobeseversusnon-obesepatientsoverthesametime
period. All of the “preconditions” were noted to have the4 ISRN Obesity
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samefindings;allthe“preconditions”werenotedtobehigher
among obese, as were morbidly obese patients versus non-
obese patients from 2000 to 2012. The OR did approximate
the IRR with respect to all these conditions. These findings
are seen in Table 3.
4. Discussion
Th i sc u r r e n ts t u d yi l l u s t r a t e st h ec h a n g ei nt h es p e c t r u m
of obesity-related comorbid conditions in an overweight,
pediatric population at a single institution over the past
decade utilizing a hospital database system. As expected,
children continue to experience the same comorbidities and
preconditions associated with obesity as compared to adults.
Amongtheweaknessesofthisstudy,perhapsthemostglaring
isthatthisadministrativedatabasemayhaveunderestimated
the overall incidence of obesity, the overall rate of obesity
being only 2-3% at our institution. However, in spite of
this, the spectrum of comorbidities seen in our pediatric
patients and the knowledge of these have significant clinical
implications. Both the medical and surgical treatment of
adult obesity has led to associated refinement of treatment
modalities; therefore, we hope to do the same with these
data that identify the vast host of comorbidities that are most
injurious to our children.
On a national level, May et al. have recently published
results regarding cardiovascular sequelae in the National
Health and Nutrition Examination Survey (NHANES) from
1999to2008[14].Again,themajorcardiovascularriskfactors
including diabetes, hypertension, and hyperlipidemia were
elevated across all cohorts but specifically increased in the
overweight and obese cohorts. Similar to their study, we
also continued to see a dose-response increase in reportable
comorbid conditions across both our obese and morbidly
obese cohorts. Unlike their study, we did not collect individ-
ual data, but rather administrative coding of diagnoses across
both inpatient and outpatient visits. Accordingly, there could
have been biased introduced with the respective coding, but
o u rh o p ei st h a tt h i sl a r g es a m p l ea m e l i o r a t e ds o m eo ft h e
associated, inherent reporting bias.
Comorbidconditionsincludingasymptomaticcardiovas-
cular risk factors (e.g., hypertension, hyperlipidemia) and
symptomatic cardiovascular risk factor (e.g., type 2 diabetes)
a r ea l s op r e v a l e n ti nb o t ht h eo b e s ea n dm o r b i d l yo b e s e
subgroups. In fact, our study shows that hyperlipidemia
a n dh y p e r t e n s i o nh a v et h eb r o a d e s te ff e c t sw i t hb o t ho u r
obese and morbidly-obese populations having the highest
weighted OR and IRR. These results are similar to results
of a population-based sample of Quebec children and ado-
lescents, where almost one-third of their obese population
hadunfavorableriskfactors;thiswasevidencedbyelevations
in apolipoprotein B, high-density lipoprotein cholesterol,
triglycerides,insulin,glucose,C-reactiveprotein,andsystolic
blood pressure [15]. Thus, despite increased awareness of
obesity and intensive medical interventions, obesity and
its associated cardiovascular disease risk factors continue
to represent an unabated major healthcare burden to this
population as a whole.
More importantly, according to Bjørge et al., it is sug-
gested that these comorbidities with cardiovascular implica-
t i o n sl e n dt oa ni n c r e a s e dr a t eo fp r e m a t u r ed e a t hi ne a r l y
adulthood after adjustment for other confounders [16]. In
juxtaposition to this, Park et al. [8]r e p o r tt h a tt h ei n c r e a s e d
risk for morbidity and mortality may be overestimated fol-
lowing adjustment for adult BMI; however, one of the limita-
tions of this study includes that it was a meta-analysis of very
small studies. When examining our data more closely, it is
very concerning the degree to which certain “preconditions”
have arisen, including acanthosis nigricans, nonalcoholic
steatohepatitis, glucose intolerance, and insulin resistance.
Theseaforementionedconditionswilleventuallybecomelife-
long diseases; therefore,it is imperativeto continueto reduce
those comorbidities with cardiovascular implications, while
a tt h es a m et i m ep r o v i d i n gm o r el o n g i t u d i n a la n a l y s i so f
obesity’s long-term effects.
Obesity and morbid obesity are not only involved in
modifiable cardiovascular risk factors, but are also intimately
involved in the respiratory system. The evidence correlating
thechangesinthereactivityandthenatureofthepulmonary
disease seen with obesity is not new. For example, the
NHANES data continues to show that excess weight has
stronger association with nonatopic asthma (OR: 2.46, 95%
CI:1.21,5.21)thanatopicasthma(OR:1.31,95%CI:0.70–2.57)
[17]. This becomes a vicious cycle for these children as they
a r eo ft e nu n a b l et op e r f o r ma c t i v i t i e so fd a i l yl i v i n ga n da r e
less likely to perform in exercise programs, which continues
to compound weight-related issues. Our data shows that,
even beyond an expected increase in asthma, there has also
been a substantial increase in those documented with sleep
apnea.Forexample,ourdatasuggeststhattheoddsofhaving
s l e e pa p n e aw a s6 . 4 8( 9 5 %C I :6 . 1 2 ,6 . 8 5 )t i m e sm o r el i k e l y
if a patient was coded as obese and 7.60 (95% CI: 7.07, 8.17)
times more likely if a patient was coded as morbidly obese as
compared to normal weight counterparts.
Similar to cardiovascular risk factors, asthma, sleep
apnea, and orthopedic problems are also increased in our
obese and morbidly obese cohorts. A common theme among
these conditions is that they limit the child or adolescent’s
ability to participate in social activities, which can further
alienate this ever-growing proportion of our society. For
example, in adults, increasing BMI and subsequent obesity
lend itself to knee pain, disability, loss of work productivity,
and diminished quality of life [18]. More recent studies in
childrensuggestthatobesechildrenreportmorefrequentand
severe joint pain with subsequent loss of function [18–21].
Our study did also evaluate the trend between obesity and
morbid obesity and depression. It is well known that obesity
in children and adolescents results in decreased/reduced
health-related quality of life [22]. As referenced by the above
orthopedic studies, depression might have been masked as
complaints of increased joint pain or inability to perform
activities performed by non-obese peers. Further studies are
needed to elucidate this connection.
Even though our study did not examine health-related
costs specifically, according to one study, the actual cost of
obesity is related to the direct costs of its associated medical
conditions [23]. Continued attention and US dollars have6 ISRN Obesity
been driven toward using policy and environmental changes
tohelpcombattheobesityepidemic;onlyinthelastdecadeor
sohadtherebeenashifttowardsmedicalandoperativeinter-
ventions. Whereas it has been shown in adults that patients
with reduced comorbid conditions attained through weight-
loss surgery live longer, the same conclusions have yet to be
applied to the pediatric population [24]. In fact, Oyetunji et
a l .r e m a r k e dt h a td e s p i t et h i si n c r e a s e dp r e v a l e n c eo fo b e s i t y
and morbid obesity among children and adolescents, only
approximately 2% of morbidly obese children with a major
comorbidity underwent a bariatric procedure [25]. This may
b ed u ei np a r tt oam y r i a do ff a c t o r si n c l u d i n gn e c e s s i t yf o r
higher volume centers for pediatric bariatric procedures, as
well as concern for permanent procedures to be performed
in children and adolescents. However, there is still a need for
novel and equitable approaches to pediatric obesity.
This study had important strengths and weaknesses. In
the future, we hope to have same functional database as,
for example, the National Surgical Quality Improvement
Program (NSQIP) database, which relies on specifically
trained personnel who use well-defined terms for data col-
lectionanddissemination.Weencounteredvisitsthathadno
documentation regarding vital data points including height,
weight, or BMI, thus contributing to the underestimation
o ft h ep r e v a l e n c eo fo b e s i t y .D e s p i t et h e s ea f o r e m e n t i o n e d
weaknesses, this study’s strengths included both its size as
well as the duration of the data collection. Obese patients,
as well as morbidly obese patients, had significant increases
in comorbid conditions including hypertension, hyperlipi-
demia, sleep apnea, orthopedic issues, and type 2 diabetes
mellitus as evidenced by the elevated IRR, OR, and tightly
controlled confidence intervals.
5. Conclusions
In conclusion, these data show the change in the spectrum of
obesity-related comorbid conditions in this pediatric popu-
lationover thepast decade. As expected, thechildren studied
have experienced the same dramatic increases in obesity as
seen in the adult population and obesity was independently
correlated with major comorbidities. Future research will be
needed to implement other treatment options to combat the
wide variety of disease sequelae.
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